549 related articles for article (PubMed ID: 27383479)
1. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
Shin S; Hwang IS; Lee ST; Choi JR
Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.
Park K; Kim MK; Lee T; Hong J; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
J Clin Lab Anal; 2020 Dec; 34(12):e23524. PubMed ID: 32812259
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
[TBL] [Abstract][Full Text] [Related]
5. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
[TBL] [Abstract][Full Text] [Related]
6. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
7. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
[TBL] [Abstract][Full Text] [Related]
8. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
10. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
Mafficini A; Simbolo M; Parisi A; Rusev B; Luchini C; Cataldo I; Piazzola E; Sperandio N; Turri G; Franchi M; Tortora G; Bovo C; Lawlor RT; Scarpa A
Oncotarget; 2016 Jan; 7(2):1076-83. PubMed ID: 26745875
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
Hwang SM; Lee KC; Lee MS; Park KU
Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
[TBL] [Abstract][Full Text] [Related]
12. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection.
Capone GL; Putignano AL; Trujillo Saavedra S; Paganini I; Sestini R; Gensini F; De Rienzo I; Papi L; Porfirio B
J Mol Diagn; 2018 Jan; 20(1):87-94. PubMed ID: 29061375
[TBL] [Abstract][Full Text] [Related]
14. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
[TBL] [Abstract][Full Text] [Related]
15. BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes.
Kechin A; Khrapov E; Boyarskikh U; Kel A; Filipenko M
Comput Biol Chem; 2018 Dec; 77():297-306. PubMed ID: 30408727
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
Trujillano D; Weiss ME; Schneider J; Köster J; Papachristos EB; Saviouk V; Zakharkina T; Nahavandi N; Kovacevic L; Rolfs A
J Mol Diagn; 2015 Mar; 17(2):162-70. PubMed ID: 25556971
[TBL] [Abstract][Full Text] [Related]
17. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2.
Schenk D; Song G; Ke Y; Wang Z
PLoS One; 2017; 12(7):e0181062. PubMed ID: 28704513
[TBL] [Abstract][Full Text] [Related]
18. Detection of false positive mutations in BRCA gene by next generation sequencing.
Suryavanshi M; Kumar D; Panigrahi MK; Chowdhary M; Mehta A
Fam Cancer; 2017 Jul; 16(3):311-317. PubMed ID: 27848044
[TBL] [Abstract][Full Text] [Related]
19. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
[TBL] [Abstract][Full Text] [Related]
20. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
